| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.481 | 0.043 | 0.481 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.365 0.135 CID_71258 | ||
| 0.382 | 0.005 | 0.382 | Toll-Like receptor 9 antagonist | 0.333 0.008 CID_71258 | ||
| 0.345 | 0.032 | 0.345 | Psychostimulant | 0.323 0.037 CID_71258 | ||
| 0.27 | 0.011 | 0.27 | Toll-Like receptor antagonist | 0.26 0.013 CID_71258 | ||
| 0.279 | 0.046 | 0.279 | Anticonvulsant | 0.155 0.123 CID_71258 | ||
| 0.249 | 0.017 | 0.287 | Hexokinase inhibitor | 0.287 0.012 CID_71258 | CID_71258 | |
| 0.31 | 0.087 | 0.31 | Angiogenesis inhibitor | 0.286 0.1 CID_71258 | ||
| 0.265 | 0.049 | 0.265 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.233 0.091 CID_71258 | ||
| 0.222 | 0.021 | 0.222 | Aurora-A kinase inhibitor | 0.142 0.043 CID_71258 | ||
| 0.304 | 0.113 | 0.337 | GABA C receptor rho-3 antagonist | 0.337 0.093 CID_71258 | CID_71258 | |
| 0.212 | 0.028 | 0.212 | Aurora-B kinase inhibitor | 0.138 0.052 CID_71258 | ||
| 0.254 | 0.072 | 0.311 | Superoxide dismutase inhibitor | 0.311 0.047 CID_71258 | CID_71258 | |
| 0.219 | 0.039 | 0.219 | Cholinergic | 0.184 0.054 CID_71258 | ||
| 0.215 | 0.036 | 0.215 | Acetylcholine M1 receptor antagonist | 0.211 0.038 CID_71258 | ||
| 0.266 | 0.092 | 0.266 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.249 0.107 CID_71258 | ||
| 0.278 | 0.107 | 0.285 | Vasodilator, coronary | 0.285 0.1 CID_71258 | CID_71258 | |
| 0.266 | 0.116 | 0.275 | Vasodilator, peripheral | 0.275 0.11 CID_71258 | CID_71258 | |
| 0.23 | 0.09 | 0.286 | Tyrosine 3 hydroxylase inhibitor | 0.286 0.04 CID_71258 | CID_71258 | |
| 0.162 | 0.023 | 0.162 | Acetylcholine agonist | 0.08 0.066 CID_71258 | ||
| 0.143 | 0.008 | 0.143 | Acetylcholine M1 receptor agonist | 0.039 0.034 CID_71258 | ||
| 0.186 | 0.052 | 0.186 | MAP kinase kinase 5 inhibitor | 0.167 0.093 CID_71258 | ||
| 0.161 | 0.037 | 0.161 | Vascular endothelial growth factor 1 antagonist | 0.1 0.065 CID_71258 | ||
| 0.186 | 0.062 | 0.186 | Src kinase inhibitor | 0.166 0.073 CID_71258 | ||
| 0.301 | 0.178 | 0.301 | MAP kinase 1 inhibitor | 0.25 0.234 CID_71258 | ||
| 0.174 | 0.052 | 0.174 | Lck kinase inhibitor | 0.144 0.069 CID_71258 | ||
| 0.172 | 0.051 | 0.172 | Ribosomal protein S6 kinase inhibitor | 0.143 0.07 CID_71258 | ||
| 0.132 | 0.012 | 0.132 | Acetylcholine muscarinic agonist | |||
| 0.302 | 0.192 | 0.364 | Caspase 9 stimulant | 0.364 0.134 CID_71258 | CID_71258 | |
| 0.188 | 0.079 | 0.188 | Focal adhesion kinase 2 inhibitor | |||
| 0.188 | 0.085 | 0.188 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.201 | 0.099 | 0.285 | Antiamyloidogenic | 0.285 0.057 CID_71258 | CID_71258 | |
| 0.114 | 0.026 | 0.114 | Fibroblast growth factor 3 antagonist | 0.076 0.056 CID_71258 | ||
| 0.105 | 0.018 | 0.105 | Cannabinoid CB2 receptor agonist | |||
| 0.103 | 0.018 | 0.103 | Phosphodiesterase VI inhibitor | 0.1 0.02 CID_71258 | ||
| 0.142 | 0.066 | 0.167 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.167 0.053 CID_71258 | CID_71258 | |
| 0.257 | 0.181 | 0.257 | MAP kinase kinase 6 inhibitor | |||
| 0.096 | 0.028 | 0.096 | Cannabinoid receptor agonist | |||
| 0.084 | 0.017 | 0.084 | Phosphodiesterase 1C inhibitor | 0.075 0.023 CID_71258 | ||
| 0.109 | 0.044 | 0.109 | mTOR complex 1 inhibitor | 0.099 0.064 CID_71258 | ||
| 0.13 | 0.064 | 0.13 | Cathepsin H inhibitor | |||
| 0.103 | 0.038 | 0.103 | Bcr-Abl kinase inhibitor | 0.101 0.041 CID_71258 | ||
| 0.132 | 0.068 | 0.132 | Acetylcholinesterase inhibitor | 0.127 0.072 CID_71258 | ||
| 0.123 | 0.064 | 0.123 | Acetylcholine muscarinic antagonist | 0.121 0.066 CID_71258 | ||
| 0.14 | 0.081 | 0.143 | Neuropeptide Y1 antagonist | 0.143 0.076 CID_71258 | CID_71258 | |
| 0.091 | 0.032 | 0.091 | Phosphodiesterase 5A inhibitor | 0.082 0.038 CID_71258 | ||
| 0.101 | 0.042 | 0.101 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.202 | 0.145 | 0.202 | Gastrin inhibitor | |||
| 0.113 | 0.058 | 0.113 | Interleukin 2 antagonist | 0.101 0.089 CID_71258 | ||
| 0.11 | 0.056 | 0.11 | Platelet activating factor beta antagonist | |||
| 0.087 | 0.035 | 0.087 | Phosphodiesterase V inhibitor | 0.079 0.042 CID_71258 | ||
| 0.232 | 0.181 | 0.352 | 15-Lipoxygenase inhibitor | 0.352 0.098 CID_71258 | CID_71258 | |
| 0.092 | 0.044 | 0.092 | mTOR complex 2 inhibitor | 0.085 0.057 CID_71258 | ||
| 0.125 | 0.078 | 0.125 | Phosphodiesterase inhibitor | |||
| 0.116 | 0.07 | 0.116 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.168 | 0.124 | 0.176 | Cyclic AMP phosphodiesterase inhibitor | 0.176 0.115 CID_71258 | CID_71258 | |
| 0.14 | 0.096 | 0.168 | CF transmembrane conductance regulator agonist | 0.168 0.049 CID_71258 | CID_71258 | |
| 0.116 | 0.076 | 0.116 | Protein kinase (CK1) delta inhibitor | |||
| 0.048 | 0.009 | 0.048 | ATM kinase inhibitor | 0.037 0.022 CID_71258 | ||
| 0.116 | 0.078 | 0.13 | MAP kinase kinase inhibitor | 0.13 0.065 CID_71258 | CID_71258 | |
| 0.112 | 0.074 | 0.112 | Vascular endothelial growth factor antagonist | |||
| 0.068 | 0.032 | 0.068 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.213 | 0.177 | 0.213 | Beta lactamase inhibitor | |||
| 0.105 | 0.07 | 0.105 | 5 Hydroxytryptamine 3A agonist | |||
| 0.114 | 0.08 | 0.114 | c-Src kinase inhibitor | 0.11 0.083 CID_71258 | ||
| 0.095 | 0.062 | 0.095 | Protein kinase C mu inhibitor | 0.085 0.074 CID_71258 | ||
| 0.11 | 0.077 | 0.11 | Beta amyloid protein antagonist | |||
| 0.135 | 0.103 | 0.136 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.136 0.101 CID_71258 | CID_71258 | |
| 0.155 | 0.123 | 0.155 | Platelet aggregation inhibitor | |||
| 0.105 | 0.074 | 0.105 | MAP kinase 13 inhibitor | |||
| 0.156 | 0.125 | 0.156 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.148 0.137 CID_71258 | ||
| 0.082 | 0.053 | 0.082 | Phosphodiesterase 3A inhibitor | 0.075 0.063 CID_71258 | ||
| 0.076 | 0.05 | 0.076 | MAP kinase 14 inhibitor | |||
| 0.113 | 0.088 | 0.113 | DNA repair enzyme inhibitor | 0.111 0.092 CID_71258 | ||
| 0.051 | 0.026 | 0.051 | Cytokine production stimulant | |||
| 0.17 | 0.145 | 0.192 | Spasmolytic | 0.192 0.127 CID_71258 | CID_71258 | |
| 0.093 | 0.068 | 0.162 | Creatine kinase inhibitor | 0.162 0.019 CID_71258 | CID_71258 | |
| 0.071 | 0.048 | 0.071 | Syk tyrosine kinase inhibitor | |||
| 0.07 | 0.048 | 0.07 | Protein kinase B alpha inhibitor | |||
| 0.056 | 0.034 | 0.056 | Toll-Like receptor 8 antagonist | |||
| 0.091 | 0.069 | 0.091 | MAP kinase kinase 1 inhibitor | 0.086 0.076 CID_71258 | ||
| 0.112 | 0.091 | 0.112 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.149 | 0.131 | 0.149 | EphB2 antagonist | |||
| 0.066 | 0.048 | 0.066 | Phosphodiesterase 4B inhibitor | |||
| 0.077 | 0.06 | 0.077 | Platelet growth factor antagonist | |||
| 0.089 | 0.072 | 0.089 | Toll-Like receptor 3 antagonist | |||
| 0.103 | 0.087 | 0.151 | MAO inhibitor | 0.151 0.06 CID_71258 | CID_71258 | |
| 0.093 | 0.078 | 0.093 | Hedgehog signaling inhibitor | |||
| 0.084 | 0.069 | 0.084 | Phosphodiesterase I inhibitor | |||
| 0.092 | 0.077 | 0.092 | Vascular endothelial growth factor 2 antagonist | |||
| 0.069 | 0.054 | 0.069 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.078 | 0.064 | 0.078 | Phosphodiesterase IV inhibitor | |||
| 0.094 | 0.08 | 0.096 | DNA intercalator | 0.096 0.077 CID_71258 | CID_71258 | |
| 0.105 | 0.091 | 0.105 | MAP kinase 12 inhibitor | |||
| 0.12 | 0.108 | 0.12 | Tyrosine kinase inhibitor | |||
| 0.082 | 0.072 | 0.082 | Pim-3 kinase inhibitor | |||
| 0.071 | 0.061 | 0.071 | Potassium channel (Tandem pore domain) blocker | |||
| 0.067 | 0.058 | 0.067 | MAP kinase 11 inhibitor | |||
| 0.034 | 0.027 | 0.034 | Adenosine uptake inhibitor | |||
| 0.074 | 0.069 | 0.074 | Neuropeptide Y antagonist | |||
| 0.113 | 0.108 | 0.113 | Cytidine deaminase inhibitor | |||
| 0.047 | 0.043 | 0.047 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.024 | 0.023 | 0.024 | Calcium-sensing receptor agonist | |||
| 0.136 | 0.144 | 0.149 | Death-associated protein kinase 2 inhibitor | 0.149 0.109 CID_71258 | CID_71258 | |
| 0.082 | 0.092 | 0.104 | Interleukin 12 antagonist | 0.104 0.048 CID_71258 | CID_71258 | |
| 0.154 | 0.169 | 0.164 | ErbB-1 antagonist | 0.164 0.146 CID_71258 | CID_71258 | |
| 0.168 | 0.194 | 0.236 | Hypoxia-inducible factor 1 alpha inhibitor | 0.236 0.114 CID_71258 | CID_71258 | |
| 0.134 | 0.164 | 0.149 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.149 0.144 CID_71258 | CID_71258 | |
| 0.195 | 0.225 | 0.31 | Alpha-glucosidase inhibitor | 0.31 0.155 CID_71258 | CID_71258 | |
| 0.062 | 0.104 | 0.091 | MAO A inhibitor | 0.091 0.07 CID_71258 | CID_71258 | |
| 0.21 | 0.257 | 0.328 | Calcium channel L-type activator | 0.328 0.134 CID_71258 | CID_71258 | |
| 0.063 | 0.116 | 0.083 | MAP kinase kinase 7 inhibitor | 0.083 0.037 CID_71258 | CID_71258 | |
| 0.104 | 0.172 | 0.133 | DNA methyltransferase I inhibitor | 0.133 0.126 CID_71258 | CID_71258 | |
| 0.101 | 0.17 | 0.149 | Heat shock protein 90 alpha antagonist | 0.149 0.088 CID_71258 | CID_71258 | |
| 0.099 | 0.185 | 0.132 | Dual specificity phosphatase inhibitor | 0.132 0.117 CID_71258 | CID_71258 | |
| 0.09 | 0.183 | 0.141 | Heat shock protein 90 antagonist | 0.141 0.084 CID_71258 | CID_71258 | |
| 0.089 | 0.191 | 0.142 | Pyruvate kinase inhibitor | 0.142 0.122 CID_71258 | CID_71258 | |
| 0.016 | 0.169 | 0.031 | Estrogen-related receptor beta antagonist | 0.031 0.026 CID_71258 | CID_71258 | |
| 0.085 | 0.243 | 0.159 | Aldehyde oxidase inhibitor | 0.159 0.131 CID_71258 | CID_71258 | |
| 0.059 | 0.243 | 0.136 | Amyloid beta aggregation inhibitor | 0.136 0.12 CID_71258 | CID_71258 | |
| 0.032 | 0.347 | 0.109 | Estrogen receptor beta antagonist | 0.109 0.048 CID_71258 | CID_71258 | |
| 0.035 | 0.406 | 0.117 | Estrogen antagonist | 0.117 0.06 CID_71258 | CID_71258 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |